Shilpa Medicare Limited
NSE:SHILPAMED.NS
852 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 11,516.03 | 10,501.124 | 11,400.493 | 9,001.59 | 8,988.751 | 7,014.708 | 7,493.565 | 7,300.693 | 6,375.782 | 5,838.931 | 5,481.763 | 3,713.234 | 3,181.819 | 2,902.857 | 2,649.12 | 1,664.322 | 958.128 |
Cost of Revenue
| 7,969.169 | 4,159.229 | 3,840.983 | 2,707.689 | 2,777.319 | 2,565.847 | 3,560.379 | 3,719.591 | 3,680.983 | 3,254.914 | 3,144.954 | 2,148.9 | 1,839.78 | 1,743.86 | 1,483.832 | 1,011.579 | 696.05 |
Gross Profit
| 3,546.861 | 6,341.895 | 7,559.51 | 6,293.901 | 6,211.432 | 4,448.861 | 3,933.186 | 3,581.102 | 2,694.799 | 2,584.017 | 2,336.809 | 1,564.334 | 1,342.039 | 1,158.997 | 1,165.289 | 652.743 | 262.078 |
Gross Profit Ratio
| 0.308 | 0.604 | 0.663 | 0.699 | 0.691 | 0.634 | 0.525 | 0.491 | 0.423 | 0.443 | 0.426 | 0.421 | 0.422 | 0.399 | 0.44 | 0.392 | 0.274 |
Reseach & Development Expenses
| 309.558 | 491.023 | 550.605 | 338.09 | 368.991 | 209.019 | 272.766 | 230.161 | 245.143 | 158.772 | 95.218 | 45.899 | 22.946 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 2,995.938 | 295.291 | 577.404 | 356.886 | 541.8 | 151.884 | 102.429 | 83.095 | 82.551 | 53.137 | 42.82 | 22.794 | 19.894 | 90.301 | 86.084 | 74.507 | 27.419 |
Selling & Marketing Expenses
| 28.681 | 26.225 | 180.165 | 119.23 | 64.239 | 46.145 | 26.867 | 22.318 | 39.522 | 33.281 | 47.572 | 23.687 | 15.129 | 6.966 | 6.136 | 4.466 | 2.552 |
SG&A
| 2,180.589 | 321.516 | 757.569 | 476.116 | 606.039 | 198.029 | 129.296 | 105.413 | 122.073 | 86.418 | 90.392 | 46.481 | 35.023 | 97.267 | 92.22 | 78.973 | 29.971 |
Other Expenses
| 81.705 | 173.997 | 107.684 | 124.716 | 26.04 | 28.564 | 28.279 | 42.673 | 17.999 | 7.614 | 23.646 | 22.506 | 10.903 | 37.996 | 41.786 | -102.726 | 81.225 |
Operating Expenses
| 2,180.589 | 6,274.069 | 6,301.2 | 5,100.988 | 4,485.022 | 3,269.478 | 2,783.042 | 2,185.55 | 1,415.664 | 1,529.264 | 1,335.536 | 1,025.541 | 840.27 | 586.648 | 531.285 | 426.293 | 111.196 |
Operating Income
| 1,366.272 | -53.995 | 1,204.088 | 1,187.744 | 1,723.129 | 1,127.544 | 1,150.144 | 1,395.552 | 1,279.135 | 1,054.753 | 1,001.273 | 538.793 | 501.769 | 572.349 | 634.004 | 226.45 | 150.882 |
Operating Income Ratio
| 0.119 | -0.005 | 0.106 | 0.132 | 0.192 | 0.161 | 0.153 | 0.191 | 0.201 | 0.181 | 0.183 | 0.145 | 0.158 | 0.197 | 0.239 | 0.136 | 0.157 |
Total Other Income Expenses Net
| -775.081 | -328.8 | -181.44 | 762.775 | 157.394 | 229.237 | 217.531 | 114.819 | -58.108 | 23.652 | -46.753 | 31.167 | 31.613 | 68.919 | 2.933 | -150.847 | 16.677 |
Income Before Tax
| 591.191 | -382.795 | 1,022.649 | 1,950.519 | 1,880.523 | 1,356.78 | 1,367.675 | 1,510.371 | 1,221.027 | 1,078.405 | 954.52 | 569.96 | 533.382 | 641.268 | 636.937 | 75.603 | 167.559 |
Income Before Tax Ratio
| 0.051 | -0.036 | 0.09 | 0.217 | 0.209 | 0.193 | 0.183 | 0.207 | 0.192 | 0.185 | 0.174 | 0.153 | 0.168 | 0.221 | 0.24 | 0.045 | 0.175 |
Income Tax Expense
| 223.855 | -73.636 | 416.827 | 488.483 | 334.918 | 261.763 | 339.057 | 446.725 | 233.879 | 352.158 | 203.025 | 95.307 | 119.034 | 146 | 210.986 | 86.027 | 54.362 |
Net Income
| 318.743 | -324.763 | 606.623 | 1,477.804 | 1,561.534 | 1,122.617 | 1,052.418 | 1,090.513 | 1,037.834 | 736.912 | 756.693 | 473.421 | 415.594 | 492.488 | 425.951 | -10.423 | 113.197 |
Net Income Ratio
| 0.028 | -0.031 | 0.053 | 0.164 | 0.174 | 0.16 | 0.14 | 0.149 | 0.163 | 0.126 | 0.138 | 0.127 | 0.131 | 0.17 | 0.161 | -0.006 | 0.118 |
EPS
| 3.67 | -3.74 | 6.99 | 18.13 | 19.15 | 13.77 | 13.07 | 13.81 | 13.59 | 9.6 | 10.68 | 6.44 | 5.72 | 7.16 | 6.45 | -0.16 | 1.77 |
EPS Diluted
| 3.67 | -3.74 | 6.99 | 18.13 | 19.15 | 13.77 | 13.07 | 13.81 | 13.59 | 9.6 | 10.19 | 6.44 | 5.72 | 7.08 | 6.45 | -0.16 | 1.77 |
EBITDA
| 2,444.971 | 1,158.716 | 2,212.89 | 1,972.261 | 2,254.435 | 1,620.36 | 1,637.852 | 1,817.288 | 1,578.582 | 1,334.069 | 1,223.25 | 742.784 | 689.967 | 702.127 | 763.534 | 321.369 | 185.991 |
EBITDA Ratio
| 0.212 | 0.11 | 0.194 | 0.219 | 0.251 | 0.231 | 0.219 | 0.249 | 0.248 | 0.228 | 0.223 | 0.2 | 0.217 | 0.242 | 0.288 | 0.193 | 0.194 |